Notably, the incidence of mucositis was further increased by the addition of AZD6738, suggesting that patients treated with PARP and/or ATR inhibitor concomitantly with their radiotherapy course of treatment could be at higher risk for severe mucositis. The gene discussed is PARP1; the disease is mucositis.